As of 2026-09-16, the Relative Valuation of Horizon Therapeutics PLC (HZNP) is 35.98 USD. This relative valuation is based on P/E multiples. With the latest stock price at 116.30 USD, the upside of Horizon Therapeutics PLC based on Relative Valuation is -69.1%.
The range of the Relative Valuation is 27.43 - 47.69 USD.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 21.7x | 15.5x |
| Forward P/E multiples | 14.7x - 20.7x | 18.4x |
| Fair Price | 27.43 - 47.69 | 35.98 |
| Upside | -76.4% - -59.0% | -69.1% |
| Date | P/E |